Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- MNMD
- Price
- 15.38
- Stock movement up
- +0.36 (2.40%)
- Company name
- Mind Medicine Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 1.50B
- Ent value
- 1.58B
- Price/Sales
- -
- Price/Book
- 11.45
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return (CAGR)
- 140.50%
- 3 year return (CAGR)
- 77.08%
- 5 year return (CAGR)
- -19.90%
- 10 year return (CAGR)
- -
Last updated: 2026-02-20
DIVIDENDS
MNMD does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 11.45 |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 97.22M |
| EPS (TTM) | -1.96 |
| FCF per share (TTM) | -1.33 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -151.19M |
| Net income (TTM) | -168.10M |
| EPS (TTM) | -1.96 |
| EPS (1y forward) | -1.77 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 19.96M |
| Net receivables | 0.00 |
| Total current assets | 215.85M |
| Goodwill | 19.92M |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 236.92M |
| Accounts payable | 8.11M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 65.42M |
| Total liabilities | 106.32M |
| Shareholder's equity | 130.60M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -113.94M |
| Capital expenditures (TTM) | 4.00 |
| Free cash flow (TTM) | -113.94M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -128.72% |
| Return on Assets | -70.95% |
| Return on Invested Capital | -98.31% |
| Cash Return on Invested Capital | -66.64% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 15.11 |
| Daily high | 15.49 |
| Daily low | 14.75 |
| Daily Volume | 1.02M |
| All-time high | 150.00 |
| 1y analyst estimate | 28.67 |
| Beta | 2.62 |
| EPS (TTM) | -1.96 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 5 Mar 2026 |
Downside potential
Loading...
Downside potential data
| MNMD | S&P500 | |
| Current price drop from All-time high | -89.75% | -0.42% |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 26 Dec 2019 | 9 Mar 2009 |
| Avg drop from high | -85.55% | -10.84% |
| Avg time to new high | 79 days | 12 days |
| Max time to new high | 1993 days | 1805 days |
COMPANY DETAILS
Marketcap
1.50B
Marketcap category
Small-cap
Description
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.
Employees
74
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner